Blockade of adenosine A2A receptor alleviates cognitive dysfunction after chronic exposure to intermittent hypoxia in

Xiu-Cui Li1, Fang-Fang Hong2, Yun-Jia Tu1

  • 1Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.

Experimental Neurology
|November 23, 2021
PubMed

Insights

Adenosine A2A receptors (A2A R) worsen cognitive deficits from sleep apnea in mice. Blocking these receptors improved memory and reduced brain damage, suggesting a therapeutic target for sleep apnea-related cognitive impairment.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Sleep Medicine

Background:

  • Obstructive sleep apnea-hypopnea syndrome (OSAHS) is linked to neurocognitive deficits, particularly in children.
  • Adenosine A2A receptors (A2A Rs) are implicated in neurodegenerative diseases and cognitive function regulation.

Purpose of the Study:

  • To investigate the role of adenosine A2A receptors (A2A Rs) in cognitive impairment induced by chronic intermittent hypoxia (CIH).
  • To evaluate the therapeutic potential of A2A R antagonists in mitigating CIH-induced cognitive dysfunction.

Main Methods:

  • Mice were exposed to chronic intermittent hypoxia (CIH) for 4 weeks.
  • Mice received daily injections of an A2A R agonist (CGS21680) or antagonist (SCH58261) prior to CIH exposure.
  • Spatial memory was assessed using the 8-arm radial arm maze; hippocampal pathology, apoptosis, and synaptic plasticity were evaluated.

Main Results:

  • CIH induced memory dysfunction, hippocampal pathology, neuronal apoptosis, and impaired synaptic plasticity.
  • A2A R stimulation exacerbated memory deficits and neuropathological damage.
  • A2A R inhibition with SCH58261 and genetic deletion of A2A Rs ameliorated cognitive impairment and neuropathology.

Conclusions:

  • Adenosine A2A receptors play a critical role in CIH-induced learning and memory impairment.
  • Blocking A2A Rs alleviates cognitive dysfunction and hippocampal damage associated with chronic intermittent hypoxia.
  • Targeting A2A Rs represents a potential therapeutic strategy for cognitive deficits in OSAHS.

Related Concept Videos